Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma

Clinical Epigenetics
Sippy KaurPäivi Peltomäki

Abstract

Altered expression of microRNAs (miRNAs) commonly accompanies colorectal (CRC) and endometrial carcinoma (EC) development, but the underlying mechanisms and clinicopathological correlations remain to be clarified. We focused on epigenetic mechanisms and aimed to explore if DNA methylation patterns in tumors depend on DNA mismatch repair (MMR) status, sporadic vs. Lynch-associated disease, and geographic origin (Finland vs. Australia). Treatment of cancer cell lines with demethylating agents revealed 109 significantly upregulated miRNAs. Seven met our stringent criteria for possible methylation-sensitive miRNAs and were used to screen patient specimens (205 CRCs and 36 ECs) by methylation-specific multiplex ligation-dependent probe amplification. Three miRNAs (129-2, 345, and 132) with low methylation levels in normal tissue and frequent hypermethylation in tumors were of particular interest. Hypermethylation of miR-345 and miR-132 associated with MMR deficiency in CRC regardless of geographic origin, and hypermethylation of miR-132 distinguished sporadic MMR-deficient CRC from Lynch-CRC. Finally, hypermethylation of miRNAs stratified 49 endometrial hyperplasias into low-methylator (simple hyperplasia) and high-methylator groups...Continue Reading

References

May 18, 2007·Annual Review of Genomics and Human Genetics·Tsung-Cheng Chang, Joshua T Mendell
Jul 17, 2007·Annals of Diagnostic Pathology·Lars-Christian HornJens Einenkel
Oct 17, 2007·Annual Review of Medicine·Einav Nili Gal-YamPeter A Jones
Oct 30, 2007·Proceedings of the National Academy of Sciences of the United States of America·Harpreet Kaur SainiAnton James Enright
Jan 15, 2008·Journal of Cellular Biochemistry·Rongxia LiaoShaoxiang Zhang
May 24, 2008·Gynecologic Oncology·Todd BorenJohnathan M Lancaster
Jun 19, 2008·Cancer Research·Emmi I JoensuuPäivi Peltomäki
Jul 11, 2008·Genes, Chromosomes & Cancer·Wade S SamowitzMartha L Slattery
Nov 29, 2008·BMC Genomics·Harpreet K SainiSam Griffiths-Jones
Dec 6, 2008·Genes & Development·Fatih OzsolakDavid E Fisher
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael T McCabePaula M Vertino
Jun 13, 2009·International Journal of Cancer. Journal International Du Cancer·Eva BandresJesus Garcia-Foncillas
Sep 3, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Taina T NieminenPäivi Peltomäki
Dec 17, 2009·Cancer Metastasis Reviews·Sylvia K Shenouda, Suresh K Alahari
Feb 10, 2010·Nature Reviews. Clinical Oncology·Eduardo Vilar, Stephen B Gruber
Apr 7, 2010·Methods : a Companion to Methods in Enzymology·Anupam PaliwalZdenko Herceg
Apr 24, 2010·The Journal of Molecular Diagnostics : JMD·Jonathan S L EarleStanley R Hamilton
Aug 13, 2010·Annals of Surgical Oncology·Iyare EsemuedePhilip B Paty
Nov 3, 2010·Nucleic Acids Research·Ana Kozomara, Sam Griffiths-Jones
Jan 20, 2011·Nature Reviews. Genetics·Eric Huntzinger, Elisa Izaurralde
Mar 2, 2011·The British Journal of Surgery·K J LeongS P Bach
Aug 17, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Francesc BalaguerAjay Goel
Sep 29, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angela N BartleyStanley R Hamilton
Oct 1, 2011·International Journal of Cancer. Journal International Du Cancer·Kuo-Wang TsaiWen-Chang Lin
Oct 27, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Taina T NieminenWael M Abdel-Rahman
Feb 9, 2012·Oncogene·A FormosaE Candi
Feb 11, 2012·Genome Biology·Hunter B FraserMichael S Kobor
May 17, 2012·Cancer Discovery·Relja Popovic, Jonathan D Licht
Jul 7, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Heejeong LeeChul Soo Park

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE55930

Methods Mentioned

BETA
methylation profiling
PCR
Feature Extraction

Software Mentioned

SPSS
MethPrimer
SPSS Statistics
Agilent
GeneSpring GX
Feature Extraction

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.